J&J Covid Shot Neutralizes Delta Variant, Company Says
Johnson & Johnson said that its single-shot coronavirus vaccine neutralizes the fast-spreading delta variant and provides durable protection against infection more broadly. Read Article
NYTJohnson & Johnson Vaccine Protects Against Delta Variant, Company Reports
The vaccine also produced long-lasting immune responses, researchers said. Booster shots seem unnecessary, at least for now. Read Article
ABCNEWSWe know vaccines are working against new COVID variants. Now scientists are starting to understand why.
After months of research, experts are seeing positive results. Read Article
NPRNew Evidence Suggests COVID-19 Vaccines Remain Effective Against Variants
The emergence of new and more infectious variants of the coronavirus has raised a troubling question: Will the current crop of COVID-19 vaccine prevent these variants from causing disease? Listen here
USA TODAYJohnson & Johnson COVID-19 vaccine protects against virus variants, study shows
Johnson & Johnson’s COVID-19 vaccine triggers several types of immune responses, a new study shows, allowing it to be extremely protective in the United States as well as in South Africa and Brazil, where a handful of different virus variants are circulating. Read Article.
Mixing COVID-19 vaccines appears to boost immune responses
n three recent studies, researchers have found that following one dose of the vaccine made by AstraZeneca with a dose of the Pfizer-BioNTech vaccine produces strong immune responses, as measured by blood tests. Two of the studies even suggest the mixed vaccine response will be at least as protective as two doses of the Pfizer-BioNTech product, one of the most effective COVID-19 vaccines. Read Article
Boston GlobeWhy does the Johnson & Johnson vaccine work against variants? A new study suggests an answer
New research suggests that Johnson & Johnson’s single-dose COVID-19 vaccine provides protection against worrisome virus variants — but perhaps not for the reasons researchers originally thought. Read Article
U.S. Moves Closer To Biden’s July 4 COVID-19 Vaccination Goal
U.S. COVID-19 cases have dropped 95% since January. At least 65% of adults have had a least one vaccine shot. President Biden aims to have 70% of adults vaccinated with at least one shot by July 4. See Article
CNNCaught in a ‘pickle,’ millions of Americans might not have had an adequate response to the Covid-19 vaccine
“It’s become such a frequent question, such a point of anxiety for patients, that last week we had three different meetings and conferences and seminars all taking about this and trying to figure out strategies about what to tell them,” Stephenson said. Read Article
